Loading…
Atyr Pharma Inc Is A Clinical-Stage Biotechnology Company Focused On Developing Therapies For Fibrosis And Inflammatory Conditions. Its Research Leverages Trna Synthetase Biology To Identify Potential Therapeutic Targets. The Company'S Discovery Platform Uses A Proprietary Library Of Domains Derived From Trna Synthetases To Explore Signaling Pathways. Its Flagship Clinical Candidate, Efzofitimod, Is A Novel Biologic Immunomodulatory In Development For The Treatment Of Interstitial Lung Disease (Ild).